Jeff Krajewski is an accomplished research scientist with extensive experience in drug discovery, particularly within the fields of ion channels and pain management. They served as a Principal Research Scientist at Eli Lilly and Company from 2010 to 2017 and continued to advance in the role of Senior Research Advisor, leading teams in the development of novel treatments for chronic pain. Previously, Jeff held the position of Senior Research Scientist at Icagen and Merck, contributing significantly to ion channel drug discovery. Jeff earned a PhD in Molecular and Cellular Pharmacology from the University of Miami and is currently pursuing a BS in Chemistry at The Ohio State University.
This person is not in any teams
This person is not in any offices